🔗 Share this article

An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Investigational Treatment Gaining Traction Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are urged to message these profiles privately for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Professionals Express Concerns

However, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could lead to users administering substances of unknown origin.

Several experts said the demand for the experimental drug could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, legal action or prison.

Platform Response and Content Elimination

Based on TikTok, the platform has taken down violative material and banned associated keywords and query recommendations. The company said it was dedicated to maintaining the platform safe and investing in enhancing compliance measures.

Online Marketplace Activities

Investigations also discovered communities with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with thousands of members, populated with photos of slimming results, positive reviews and step-by-step instructions for mixing or injecting at residence.

Within moments of joining one community, a vendor shared contact information, where most purchases take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.

Product Information and Costs

Inside these groups, messages show dark colored packages with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors typically sold at £160 for 20mg. When asked how long a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for Telegram said it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting substances they can’t verify. Although the research behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the increase in interest to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has previously seen individuals injured by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may subject users to potentially significant health risks”.